Literature DB >> 29327316

[Diagnosis, differential diagnosis and therapy of substance use disorders in general hospital (general section)].

Anton Schmick1, Josef Jenewein2, Sönke Böttger2.   

Abstract

Substance use disorders are becoming an increasingly significant problem in general hospitals and hence play a key role in consultation- and liaison psychiatry. Diverse psychotropic effects of various substances mimic psychiatric disorders. An alcohol intoxication can present depressive or manic symptoms, a cannabis delirium can present as a psychosis while stimulants use can suggest the diagnosis of an anxiety disorder. Obtaining dual diagnoses by identifying substance-induced and non-substance-induced psychopathologies is clinically challenging.The aim of this article is to systematically describe the psychopathology, pathophysiology and therapeutic options of substance-use disorders particularly relevant for consultation and liaison psychiatry.

Entities:  

Keywords:  Alcohol; Cannabis; General hospital psychiatry; Opiates; Substance use disorders

Mesh:

Year:  2018        PMID: 29327316     DOI: 10.1007/s40211-017-0257-7

Source DB:  PubMed          Journal:  Neuropsychiatr        ISSN: 0948-6259


  32 in total

Review 1.  Emerging drugs for the treatment of tobacco dependence: 2014 update.

Authors:  Muhamad Y Elrashidi; Jon O Ebbert
Journal:  Expert Opin Emerg Drugs       Date:  2014-03-22       Impact factor: 4.191

2.  Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.

Authors:  Ralitza Gueorguieva; Ran Wu; Dennis Donovan; Bruce J Rounsaville; David Couper; John H Krystal; Stephanie S O'Malley
Journal:  Drug Alcohol Depend       Date:  2009-12-06       Impact factor: 4.492

Review 3.  False-positive interferences of common urine drug screen immunoassays: a review.

Authors:  Alec Saitman; Hyung-Doo Park; Robert L Fitzgerald
Journal:  J Anal Toxicol       Date:  2014-07-01       Impact factor: 3.367

4.  Substance use in the general hospital.

Authors:  Christos Kouimtsidis; Martina Reynolds; Mary Hunt; Jackie Lind; Jonathan Beckett; Colin Drummond; Hamid Ghodse
Journal:  Addict Behav       Date:  2003-04       Impact factor: 3.913

Review 5.  Pharmacotherapy of addictive disorders.

Authors:  Stephen Ross; Eric Peselow
Journal:  Clin Neuropharmacol       Date:  2009 Sep-Oct       Impact factor: 1.592

Review 6.  Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.

Authors:  Julia M A Sinclair; Sophia E Chambers; Celia J Shiles; David S Baldwin
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

Review 7.  Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence.

Authors:  N S Miller; M S Gold
Journal:  Am Fam Physician       Date:  1998-07       Impact factor: 3.292

Review 8.  New insights on the antidepressant discontinuation syndrome.

Authors:  Brian H Harvey; Francois N Slabbert
Journal:  Hum Psychopharmacol       Date:  2014-11       Impact factor: 1.672

9.  Issues in the management of acute agitation: how much current guidelines consider safety?

Authors:  Bruno Pacciardi; Mauro Mauri; Claudio Cargioli; Simone Belli; Biagio Cotugno; Luca Di Paolo; Stefano Pini
Journal:  Front Psychiatry       Date:  2013-05-07       Impact factor: 4.157

10.  Topical corticosteroid addiction and phobia.

Authors:  Aparajita Ghosh; Sujata Sengupta; Arijit Coondoo; Amlan Kusum Jana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.